Global Cord Blood Corp Receivables Turnover Ratio (CO), from the fourth quarter 2022 to the fourth quarter 2021 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Global Cord Blood Corp  (NYSE: CO)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Global Cord Blood Accounts Receivables Turnover Ratio from the fourth quarter 2022 to the fourth quarter 2021

Quarterly Results, Trends, Rankings, Statistics


Global Cord Blood Corp's ability to collect accounts receivable sequentially worsen to 6.2, pointing to a challenging and on top of that deteriorating business climate for the Healthcare Facilities industry. Global Cord Blood's Accounts Receivable average collection period in the Mar 31 2022 quarter, has increased to 59 days, from 57 days, in the 0 quarter.

If we take a look into Healthcare sector 132 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 1306.

What is Receivable Turnover Ratio?
What is Global Cord Blood Corp Selling?


What is Receivable Turnover Ratio?





CO Receivables Turnover Ratio (Mar 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Mar 31 2021)
IV. Quarter
Y / Y Receivable Change 30.78 % 35.07 % 25.23 % 35.07 % 38.26 %
Y / Y Revenue Change 10.8 % - - - 2.6 %
Receivable Turnover Ratio (TTM) 6.2 6.36 8.49 8.87 9.35
CO's Total Ranking # 1306 # 1306 # 0 # 1307 # 0
Accounts Receivable average collection period days 59 57 43 41 39
Seq. Receivable Change 223.07 % -11.42 % 12.9 % -59.52 % 233.69 %
Seq. Revenue Change - - - - 265.08 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 13
Healthcare Sector # 133
Overall Market # 1306

Receivable Turnover Ratio Statistics
High Average Low
11.72 8.77 5.28
(Mar 31 2020)   (Mar 31 2016)






Financial Statements
Global Cord Blood's Accounts Receivable $ 64 Millions Visit CO's Balance sheet
Global Cord Blood's Sales TTM $ 196 Millions Visit CO's Income Statement
Sources of CO's Revenues Visit CO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CO's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CO's Growth Rates CO's Roa CO's Inventory Turnover Ratio CO's Dividend Comparisons
CO's Profitability Ratios CO's Roi CO's Asset Turnover Ratio CO's Dividend Growth
CO's Valuation Ratios CO's Roe CO's Financial Strength Ratios CO's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2022 Receivable at quarter ending Mar 31 2022
Privia Health Group Inc   8.38 $ 1,066.414  Millions$ 127.224  Millions
Ensign Group Inc  8.37 $ 2,713.653  Millions$ 324.035  Millions
Glaukos Corp  8.33 $ 293.724  Millions$ 35.262  Millions
Becton Dickinson And Company  8.33 $ 19,211.000  Millions$ 2,307.000  Millions
Biodesix Inc   8.31 $ 32.188  Millions$ 3.874  Millions
Hanger inc.  8.28 $ 1,144.305  Millions$ 138.186  Millions
The Pennant Group Inc   8.28 $ 447.941  Millions$ 54.099  Millions
Angiodynamics Inc   8.27 $ 306.063  Millions$ 37.009  Millions
Cerus Corporation  8.25 $ 198.137  Millions$ 24.019  Millions
Acadia Pharmaceuticals Inc   8.25 $ 493.059  Millions$ 59.786  Millions
Encompass Health Corporation  8.22 $ 5,224.800  Millions$ 635.500  Millions
Exact Sciences Corporation  8.22 $ 1,846.001  Millions$ 224.595  Millions
Cytosorbents Corporation  8.21 $ 41.258  Millions$ 5.024  Millions
Atricure Inc   8.20 $ 289.630  Millions$ 35.308  Millions
Prestige Consumer Healthcare Inc   8.19 $ 1,086.812  Millions$ 132.725  Millions
Vapotherm Inc   8.19 $ 102.606  Millions$ 12.533  Millions
Elutia Inc   8.13 $ 46.001  Millions$ 5.659  Millions
Tela Bio Inc   8.13 $ 31.817  Millions$ 3.916  Millions
Scienture Holdings Inc   8.09 $ 9.172  Millions$ 1.133  Millions
Dynatronics Corporation  8.08 $ 45.385  Millions$ 5.614  Millions
Aveanna Healthcare Holdings Inc   8.04 $ 1,711.992  Millions$ 212.923  Millions
Nuwellis Inc   8.04 $ 7.929  Millions$ 0.987  Millions
Clever Leaves Holdings Inc   7.98 $ 17.121  Millions$ 2.146  Millions
Xtant Medical Holdings Inc   7.95 $ 55.680  Millions$ 7.001  Millions
Amedisys Inc  7.93 $ 2,222.225  Millions$ 280.332  Millions
Tandem Diabetes Care Inc   7.92 $ 737.669  Millions$ 93.133  Millions
Cutera Inc   7.90 $ 239.616  Millions$ 30.320  Millions
Standard Biotools Inc   7.87 $ 124.291  Millions$ 15.785  Millions
Moderna Inc   7.85 $ 22,600.000  Millions$ 2,877.500  Millions
Pfizer Inc  7.83 $ 92,367.000  Millions$ 11,797.000  Millions

Date modified: 2026-10-07T00:41:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.